• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

drug manufacturing

Asia
Pharma

AstraZeneca-CSPC, FDA, NMPA—Fierce Pharma Asia

AstraZeneca penned a discovery pact with China's CSPC Pharma. The FDA halted new trials that export U.S. individuals' living cells to China. And more.
Angus Liu Jun 20, 2025 11:28am
A sign reading tariffs in front of a stock ticker and the US Capitol building

Trump rekindles pharmaceutical tariff threat: Reuters

Jun 17, 2025 11:21am
Back side of Capitol building

Senators bring back bill to bolster US pharma supply chain

Jun 17, 2025 8:40am
closed

CDMO Resilience to streamline with the closing of 6 facilities

Jun 10, 2025 9:30am
capsules money profits finances tariffs

Drugmakers, trade groups and others hit back on tariff threat

May 29, 2025 10:50am
CRL RTF rejection

Savara's lung disease asset hit with FDA refuse-to-file letter

May 27, 2025 10:35am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings